MacroGenics Stock Target Price and Analyst Consensus
| MGNX Stock | USD 16.10 0.58 3.48% |
The current analyst and expert consensus on MacroGenics is Strong Buy, with 7 strong buy opinions. The current projected MacroGenics target price consensus is 12.38 with 11 analyst opinions. The most common way MacroGenics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview MacroGenics executives and customers to further validate their buy or sell advice. MacroGenics buy-or-sell recommendation module provides average expert sentiment on the projected MacroGenics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on MacroGenics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.
Lowest Forecast 11.27 | Highest Forecast 13.74 | Target Price 12.38 |
MacroGenics |
It's important to approach MacroGenics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize MacroGenics price targets
MacroGenics' stock target price is an estimate of its future price, usually made by analysts. Using MacroGenics' target price to determine if it is a suitable investment can be done through the following steps:- Look at MacroGenics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if MacroGenics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional MacroGenics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of MacroGenics is a key component of MacroGenics valuation and have some predictive power on the future returns of a MacroGenics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MacroGenics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 70 shares | |
 | Chemicals Invested over 40 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Cash Cows Invested few shares | |
Check out Macroaxis Advice on MacroGenics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for MacroGenics Stock analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
The data published in MacroGenics' official financial statements usually reflect MacroGenics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of MacroGenics. For example, before you start analyzing numbers published by MacroGenics accountants, it's critical to develop an understanding of what MacroGenics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of MacroGenics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MacroGenics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in MacroGenics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MacroGenics. Please utilize our Beneish M Score to check the likelihood of MacroGenics' management manipulating its earnings.